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The distribution of telomerase activity in patients with
Helicobacter pylori positive gastritis
Naime CANORUÇ1, Ebru KALE1, Şerif YILMAZ2, Kadim BAYAN2, Mehmet DURSUN2,
Sabri BATUN1, Abdurrahman KAPLAN1

Aim: Helicobacter pylori is considered a class I carcinogen by the World Health Organization. We aimed to determine
whether H. pylori has an effect on telomerase activity in patients with H. pylori related non-specific gastritis, atrophy, and
intestinal metaplasia.
Materials and methods: One hundred and seventy-two adult patients who underwent upper gastroduodenoscopy were
enrolled in the study. Three biopsy specimens were taken from the antrum: 1 from the incisura angularis and 2 from the
mid-antrum. Biopsy specimens taken from the incisura angularis were evaluated using the urease test for detection of
H. pylori. The mid-antrum specimens were sent for histopathology and tissue telomerase activity testing. The
histopathologic evaluation was performed based on the updated Sydney system. Quantitative detection of hTERT mRNA
was performed with the available method for telomerase activity.
Results: Of the 172 patients, 119 were eligible for the study. H. pylori was positive in 68 (57.14%) and negative in 51
(42.85%) of the cases (P > 0.05). Of the 119 patients, 6 had intestinal metaplasia, 27 had glandular atrophy, 62 had
neutrophilic activation, and 102 had chronic inflammation. The telomerase activity of the H. pylori positive and negative
groups did not show a statistically significant difference in patients with intestinal metaplasia, glandular atrophy,
neutrophilic activation, and chronic inflammation (P > 0.05, for each). hTERT activity was higher in H. pylori positive
patients who had glandular atrophy and intestinal metaplasia than the negative group. However, the differences were
insignificant.
Conclusion: We could not find any significant relationship between telomerase activity and H. pylori related non-specific
gastritis, atrophy, and intestinal metaplasia. hTERT activity was higher in patients who had glandular atrophy and
intestinal metaplasia (early stages of gastric carcinogenesis) in the H. pylori positive group. However, these differences
were not significant. H. pylori, which is considered an oncogenic agent, may influence telomerase activity of further
stages of carcinogenesis, particularly those after intestinal metaplasia.
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Helicobacter pylori positif gastritli hastalarda telomeraz aktivitesinin dağılımı
Amaç: Helicobacter pylori Dünya Sağlık Örgütü tarafından class I karsinojen olarak kabul edilmiştir. Biz H. pylori ile
ilişkili non-specific gastrit, atrofi ve intestinal metaplazi tespit edilen hastalarda, H. pylori’nin telomeraz üzerine etkisi olup
olmadığını araştırmayı amaçladık.
Yöntem ve gereç: Gastroduodenoscopy yapılıp gastirit tanısı konulmuş 172 hasta çalışmaya dahil edilmiştir. Bu
hastalardan, 1 tanesi incisura angularis, diğer 2si de mid-antrumdan olmak üzere üç biyopsi örneği alınmıştır. İncisura
angularisden alınan biyopsi örneklerinde H. pylori varlığını göstermek için üreaz testi kullanılmıştır. Mid-antrumdan
alınan iki örneğin biri histopatolojik incelemede, diğeri de telomeraz aktivite tayininde kullanılmıştır. Histopatholojik
değerlendirme için update edilmiş Sydney sistemi kullanılmıştır. hTERT’in kantitatif analizi ile telomeraz aktivite tayini
yapılmıştır.
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Bulgular: Yüz yetmişiki hastanın 119 çalışmaya dahil edilmiştir. Vakaların 68 (57,14%) tanesinde H. pylori pozitif ve 51
(% 42,85)’inde negatif (P > 0,05) idi. Hastalardan, 119’unun 6’sında intestinal metaplazi, 27’sinde glandular atrofi, 62’sinde
nötrofilik aktivasyon ve 102’sinde kronik inflamasyon görüldü. H. pylori positif ve negatif gruplar arasında telomeraz
aktivitesinde istatistiksel olarak önemli bir farklılık yoktu (P > 0,05, herbiri için). hTERT aktivitesi, glandular atrofi ve
intestinal metaplazisi olan H. pylori positif grubunda negatif olanlara gore daha yüksek olmasına rağmen istatistiksel
açıdan önemli değildir.
Sonuç: Biz telomeraz aktivitesi ile, H. pylori ile ilişkili non-specific gastrit, atrofi ve intestinal metaplasia arasında
istatistiksel açıdan önemli bir farklılık bulamadık. H. pylori pozitif glandular atrofi ve intestinal metaplazili hastalarda
HTERT aktivitesini (gastrik karsinogenezin erken basamağı olan) daha yüksek bulduk. Fakat bu değişiklikler istatistiksel
açıdan anlamlılık göstermedi. Onkojenik bir ajan olan H. pylori’nin karsinogenezin intestinal metaplaziden daha sonraki
basamaklarını etkileyerek telomeraz aktivitesini artırdığı düşünülmektedir.
Anahtar sözcükler: Helicobacter pylori, telomeraz

Introduction
Telomeres are specialized heterochromatic
structures at the ends of vertebrate chromosomes that
have been implicated in stabilizing, protecting, and
anchoring chromosomes within the nucleus, as well
as assisting the replication of linear DNA (4).
Telomeric repeats are lost with each cell division
because DNA polymerases cannot replicate the very
end of a linear DNA molecule. In contrast, activation
of telomerase, the enzyme that synthesizes telomeric
DNA, is proposed to be an essential step in cancer cell
immortalization and cancer progression (1).
Gastric cancer is thought to be a multistep
progression from chronic gastritis, atrophy, and
intestinal metaplasia ultimately to dysplasia and
cancer (2). Helicobacter pylori (H. pylori) is a gramnegative spiral microorganism that occurs in the
human stomach. It was first cultured in vitro in 1983.
Epidemiologic evidence strongly supports a causal
role for H. pylori in gastric carcinogenesis. In addition,
the infection was recognized as a Class I human
carcinogen by the International Agency for Research
on Cancer in 1994. H. pylori infection predisposes to
gastric cancer and contributes to the induction of
chronic atrophic gastritis and precancerous lesions,
such as intestinal metaplasia (3).
Little is known about the influence of H. pylori
infection on genetic alterations and cell immortality
in the gastric mucosa. In this study, we aimed to
determine whether H. pylori has an effect on
telomerase activity in patients with H. pylori related
non-specific gastritis, atrophy and intestinal
metaplasia. To our knowledge, there is no study in the
literature reporting quantitative values in H. pylori
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gastritis patients. We also tried to evaluate the
quantitative detection of hTERT mRNA by real-time
fluorescence RT-PCR, a new molecular diagnostic
parameter in the work-up of H. pylori gastritis.
Materials and methods
This study was carried out at the Gastroenterology
Endoscopy Unit and Clinical Biochemistry
Department of the University Hospital in Diyarbakir,
between September 2004 and January 2005. We
studied 172 patients with dyspeptic symptoms who
had undergone upper gastrointestinal endoscopy. The
study was approved by the local ethics committee, and
all subjects were recruited in a voluntary manner,
giving their written informed consent. Endoscopy was
performed using an Olympus GIF-V-70 device. The
patients had not been treated for H. pylori before. A
total of 3 biopsies were taken form each patient using
Olympus FB-25K biopsy forceps: 1 from the incisura
angularis, and 2 from the mid-antrum. Of the 2
specimens obtained from the mid-antrum, 1 was
placed in a separate tube filled with 10% formalin,
labeled, and sent to the pathology laboratory, while
the other biopsy specimen taken from the antrum was
frozen in liquid nitrogen and stored at −80 °C until
the analysis of human telomerase reverse
transcriptase (hTERT). The biopsy specimens taken
from the incisura angularis were placed in tubes
containing urease solution and incubated at 37 °C for
2 h. The turning of the solution’s color to pink was
accepted as a positive test for H. pylori while no
changes in color were accepted as a negative test.
Histopathology of gastritis was classified according to
the updated Sydney classification system (4).
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Total RNA from the frozen tissue specimens was
isolated using “High Pure RNA Tissue Kit” (Roche
Diagnostics, Germany). Tissue specimens were
crushed using a porcelain mortar and homogenized
with “Lysis/Binding Buffer”. The obtained total RNA
was stored at −80 °C until the analysis of hTERT.
Quantitative detection of hTERT mRNA was
performed with the commercially available
“LightCycler TeloTAGGG hTERT Quantification Kit”
(Roche Diagnostics, Germany), using the light-cycler
instrument (Roche Diagnostics, Germany).
The recently introduced Light Cycler is a
thermocycler with on-line monitoring of PCR. The
amplicon is detected by fluorescence using 2 short
oligonucleotides that hybridize to an internal
sequence of the amplified fragment during the
annealing phase of the PCR cycles. One probe is
labeled with a fluorescent dye at the 5th end, with
another at the 3rd end. The probes are designed to
hybridize to the target strand so that the 2 dyes can be
in close proximity and fluorescence resonance energy
transfer can take place between the 2 fluorophores.
This leads to the emission of fluorescence, which is
detected on-line during the PCR cycles.
Statistical analysis was carried out by using SPSS
10.0, and a P value lower than 0.05 was considered to
be statistically significant.

telomerase activity and hTERT values were not
significantly different in H. pylori positive and
negative samples in terms of chronic inflammation (P
= 0.52 and P = 0.46, respectively).
Telomerase activity of H. pylori positive and
negative samples, and hTERT median values were
evaluated with the same test in neutrophil activity
positive and negative patients. Telomerase activity and
hTERT were not significantly different in H. pylori
positive and negative samples in terms of neutrophil
activation (P = 0.93 and P = 0.59, respectively).
Telomerase activity of H. pylori positive and
negative samples and hTERT median values were
evaluated in glandular atrophy positive and negative
patients. Telomerase activity and hTERT values were
higher in H. pylori positive than negative samples
(telomerase activity 836 vs. 454; hTERT: 1433 vs.
1391). However, the difference was not statistically
significant (P = 0.71 and P = 0.13, respectively)
(summarized in Table 1).
Table 1. Median values of telomerase activity and hTERT in H.
pylori positive and negative patients with atrophy and
intestinal metaplasia.
Atrophy

H. pylori

Results
Of the 172 patients, 119 were included in the study
while 53 patients were excluded, 24 were not classified
according to the Sydney classification system during
histopathological evaluation, and 29 were not
detected for RNA. In the study group, 75 were female
and 44 were male and their mean ages were 40.29 ±
14.21 and 42.07 ± 15.72, respectively. H. pylori was
positive in 68 (57.14%) and negative in 51 (42.85%)
patients. Telomerase activity was positive in 83
(69.74%) and negative in 36 (30.25%) patients.
Intestinal metaplasia was present in 6, glandular
atrophy in 27, neutrophil activation in 62, and chronic
inflammation in 102 of the 119 patients.
Telomerase activity of H. pylori positive and
negative samples, and hTERT median values were
evaluated by Mann-Whitney U test in chronic
inflammation positive and negative patients. Median

Intestinal Metaplasia
H. pylori

hTERT

TA
(Median)

(Median)

Positive
Negative

1433
1391

836
454

Positive
Negative

1862
1422

1867
752

(TA: Telomerase activity)

Telomerase activity of H. pylori positive and
negative samples and hTERT median values were also
evaluated in intestinal metaplasia positive and
negative patients. Telomerase activity and hTERT
values were higher in all H. pylori positive metaplastic
patients (telomerase activity 1867 vs. 752; hTERT:
1862 vs. 1422) (summarized in Table 1). We could not
compare these results with the H. pylori negative ones
since all intestinal metaplasia patients were H. pylori
positive.
H. pylori positive and negative patients were also
classified according to their telomerase activity.
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Telomerase activity of chronic inflammation,
neutrophil activity, and glandular atrophy positive and
negative samples were not significantly different in the
H. pylori positive group (P = 0.56; P = 0.63; P = 0.63,
respectively). Telomerase activity of these 3
parameters was also insignificant in the H. pylori
negative group (P = 0.37; P = 0.43; P = 0.84,
respectively) (Table 2).
Discussion
Recently, a sensitive polymerase chain reaction
(PCR)-based telomerase assay, designed for the
telomeric repeat amplification protocol (TRAP), has
been used to investigate human telomerase activity for
cancer and aging research (6). Telomerase activity
appears in 85% of human cancers, including breast,
bladder, colon, prostate, and liver, and so telomerase
may be used as a molecular marker for cancer
diagnosis and therapeutic strategies (7). Telomerase
activity is also found in precancerous lesions (i.e.
gastric intestinal metaplasia and adenomas in the
colon mucosa) (8).
Recent epidemiologic evidence indicates that H.
pylori infection increases the risk of gastric carcinoma.
Infection with H. pylori leads to chronic atrophic
gastritis, which frequently advances to intestinal
metaplasia, occasionally to dysplasia, and rarely to
carcinoma. H. pylori infection increases the rate of
proliferation of the gastric epithelial cells and
decreases the gastric secretion of ascorbic acid,
processes that may modulate the process of
carcinogenesis (9).
The presence of H. pylori in the gastric mucosa is
almost always associated with intense submucosal

inflammation with infiltration by neutrophils and
monocytes. H. pylori induced gastric pathology shares
the same proinflammatory mediator profiles as many
other systemic diseases (10). The incriminating
proinflammatory mediators include leukotriene-B4
(LT-B4), which promotes neutrophil migration and
degranulation; interleukin-1β (IL-1 β), which
mediates inflammation; tumor necrosis factor-α
(TNF- α), which interacts synergistically with
interleukin-1 (IL-1); and interleukin-8 (IL-8), which
is one of the most potent chemoattractants that also
degranulate neutrophils in different organs in the
body (11). TNF-α, IL-1β, and IL-8 levels are all raised
in gastric mucosa of patients with H. pylori infection
compared with those who are not infected. Local
production of inflammatory cytokines can induce
telomerase activity in inflammatory mucosa. H. pylori
stimulates lymphocytic infiltration of the mucosal
stroma and this infiltration may act as a focus for
cellular alteration and proliferation, ultimately
resulting in neoplastic transformation of cells. It has
been reported that infiltrating lymphocytes express
telomerase activity in inflammatory tissues (12,13).
Telomerase activity was reported to be higher in
intestinal-type gastric cancer than in the diffuse type.
How H. pylori infection induces high telomerase
activity is not clear. One explanation is that H. pylori
infection may influence the negative regulator of
telomerase activity during the early stages of stomach
carcinogenesis (14). In a previous study, it was
reported that telomerase activity was higher in
intestinal metaplasia with H. pylori infection than in
that without infection. Telomerase is associated with
the severity and extent of intestinal metaplasia and H.
pylori eradication may improve the endoscopic and

Table 2. Results in Sydney criteria of H. pylori positive and negative patients in terms of telomerase activity.

Telomerase Activity Positive
H. pylori positive (n/%)

H. pylori negative (n/%)

P value

Chronic inflammation positive

51 (70%)

22 (30%)

0.639

Neutrophil activation positive

40 (85%)

7 (15%)

0.059

Glandular atrophy positive

13 (72%)

5 (28%)

0.470

Intestinal metaplasia positive

6 (100%)

0 (0%)

–
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histologic features of intestinal metaplasia, and
decrease telomerase activity (3). Our study also
indicated that H. pylori positive samples’ telomerase
activity and hTERT median values were higher in
intestinal metaplasia positive patients than the
negative samples.
Zhang et al. found higher telomerase activity in H.
pylori positive patients with chronic atrophic gastritis
and intestinal metaplasia (67.9%) than H. pylori
negative patients (21.4%) (15). Yao et al. studied
telomerase activity of 30 patients with chronic
superficial gastritis (44 with precancerous lesions and
42 with gastric cancer) using in situ hybridization and
found telomerase activities to be 0%, 36%, and 86%,
respectively (16).
In our study, telomerase activity of H. pylori
positive patients with glandular atrophy was not
significantly different from that of H. pylori negative
patients (P > 0.05). Both H. pylori infection and
telomerase activity were positive in 44% of patients
with glandular atrophy. H. pylori infection and
telomerase activity were negative in 15% of patients
with glandular atrophy. H. pylori infection was higher
in intestinal metaplasia and telomerase activity
positive patients. Suzuki et al. found the hTERT gene
expression to be positive in 16% of chronic gastritis
patients without intestinal metaplasia (17). In our
study, we found telomerase activity to be higher in H.
pylori positive (41%) patients than in H. pylori
negative (16%) patients with gastritis but without
intestinal metaplasia.

Chung et al. reported that telomerase activity
increased in 18% of patients with type III intestinal
metaplasia (18). In our intestinal metaplasia group, 4
of the 6 patients had high telomerase activity and H.
pylori positivity. Two of the 6 patients had high
telomerase activity but H. pylori was negative in them.
It was also reported that hTERT expression was higher
in the H. pylori infected group than in the noninfected group in chronic gastritis patients (19).
This study has additional value in terms of the
study protocol. We provided the quantitative values
of telomerase activity by real-time fluorescence RTPCR, a new molecular diagnostic parameter in the
workup of H. pylori gastritis.
Conclusion
In our study, we did not find any relationship
between H. pylori infection and telomerase activity in
the presence of neutrophil activation and chronic
inflammation in patients with gastritis. Although
hTERT activation was higher in patients with
glandular atrophy and intestinal metaplasia in H.
pylori positive samples than in H. pylori negative
samples, a statistical significance was not found. Our
data suggest that H. pylori, as an oncogenic bacterium
causing non-specific gastritis, intestinal metaplasia,
and glandular atrophy, is not related to telomerase
activity. These data support the hypothesis that H.
pylori may increase the risk of gastric cancer after the
step of intestinal metaplasia.
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